What's new in tocolytics

M. R. Leonardi, Gary Hankins

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Tocolytic therapy represents the final obstetric end point in the prevention of premature births. For the past two decades, betamimetic therapy has been the mainstay of tocolytic therapy. Newer agents, indomethacin and nifedipine, offer new hope in the treatment of premature labor. With the introduction of these newer agents, combination drug therapy appears to be on the horizon.

Original languageEnglish (US)
Pages (from-to)367-384
Number of pages18
JournalClinics in Perinatology
Volume19
Issue number2
StatePublished - 1992
Externally publishedYes

Fingerprint

Tocolytic Agents
Tocolysis
Adrenergic beta-Agonists
Premature Obstetric Labor
Premature Birth
Nifedipine
Combination Drug Therapy
Indomethacin
Obstetrics
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Leonardi, M. R., & Hankins, G. (1992). What's new in tocolytics. Clinics in Perinatology, 19(2), 367-384.

What's new in tocolytics. / Leonardi, M. R.; Hankins, Gary.

In: Clinics in Perinatology, Vol. 19, No. 2, 1992, p. 367-384.

Research output: Contribution to journalArticle

Leonardi, MR & Hankins, G 1992, 'What's new in tocolytics', Clinics in Perinatology, vol. 19, no. 2, pp. 367-384.
Leonardi MR, Hankins G. What's new in tocolytics. Clinics in Perinatology. 1992;19(2):367-384.
Leonardi, M. R. ; Hankins, Gary. / What's new in tocolytics. In: Clinics in Perinatology. 1992 ; Vol. 19, No. 2. pp. 367-384.
@article{f8ae645030ef49c5b0aeb7280455f530,
title = "What's new in tocolytics",
abstract = "Tocolytic therapy represents the final obstetric end point in the prevention of premature births. For the past two decades, betamimetic therapy has been the mainstay of tocolytic therapy. Newer agents, indomethacin and nifedipine, offer new hope in the treatment of premature labor. With the introduction of these newer agents, combination drug therapy appears to be on the horizon.",
author = "Leonardi, {M. R.} and Gary Hankins",
year = "1992",
language = "English (US)",
volume = "19",
pages = "367--384",
journal = "Clinics in Perinatology",
issn = "0095-5108",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - What's new in tocolytics

AU - Leonardi, M. R.

AU - Hankins, Gary

PY - 1992

Y1 - 1992

N2 - Tocolytic therapy represents the final obstetric end point in the prevention of premature births. For the past two decades, betamimetic therapy has been the mainstay of tocolytic therapy. Newer agents, indomethacin and nifedipine, offer new hope in the treatment of premature labor. With the introduction of these newer agents, combination drug therapy appears to be on the horizon.

AB - Tocolytic therapy represents the final obstetric end point in the prevention of premature births. For the past two decades, betamimetic therapy has been the mainstay of tocolytic therapy. Newer agents, indomethacin and nifedipine, offer new hope in the treatment of premature labor. With the introduction of these newer agents, combination drug therapy appears to be on the horizon.

UR - http://www.scopus.com/inward/record.url?scp=0026642902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026642902&partnerID=8YFLogxK

M3 - Article

C2 - 1352193

AN - SCOPUS:0026642902

VL - 19

SP - 367

EP - 384

JO - Clinics in Perinatology

JF - Clinics in Perinatology

SN - 0095-5108

IS - 2

ER -